About GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
L'hôpital Cochin est un hôpital de l'Assistance publique - hôpitaux de Paris dans le 14ᵉ arrondissement de Paris. Il dépend de la faculté de médecine de l'université Paris-Cité. Il est situé 27 rue du Faubourg-Saint-Jacques.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
During the past decade, GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur"
#1 collaborator was "COVIREIVAC" with 1 trials as a collaborator and "IREIVAC/COVIREIVAC Network" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
According to Clinical.Site data, the most researched conditions in "GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur" are
"COVID-19" (1 trials), "COVID-19 Vaccines" (1 trials) and "Vaccine Reaction" (1 trials). Many other conditions were trialed in "GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur" in a lesser frequency.
Clinical Trials Intervention Types at GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Most popular intervention types in "GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "CoV2 preS dTM adjuvanted vaccine (B.1.351), Sanofi/GSK" (2 trials), "2nd booster with Comirnaty® (Pfizer-BioNTech)" (1 trials), "BNT162b2" (1 trials) and "CoV2 preS dTM adjuvanted vaccine (D614), Sanofi/GSK" (1 trials). Other intervention names were less common.
Clinical Trials Genders at GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
The vast majority of trials in "GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur" are
2 trials for "All" genders.
Clinical Trials Status at GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Currently, there are NaN active trials in "GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".